West Kendall Baptist Hospital – Scholarly Showcase: Molecular Targeted Therapy and Immunotherapy, the Advent of a New Era for the Practicing Physician
Molecular profiling may help meet the needs of predictive biomarkers in immunotherapeutic treatments. Understanding newly identified mechanisms for cancer growth and the availability of clinical trials can positively affect the outcome of cancer patients.
Hospitalists, Pulmonologists, Internists, Residents, Nurse Practitioners, Physician Assistants, Nurses, Pharmacists, Respiratory Therapists, Laboratory Technicians, Occupational Therapists and any other interested healthcare professionals.
- List newly identified mechanism for cancer growth.
- Identify the availability of approved therapies for cancers that have produced a change in standard practice.
- Assess clinical trials that can positively affect the outcome of cancer patients.
Miguel A. Villalona-Calero, M.D., FAAAS, FACP
Deputy Director and Chief Scientific Officer
Miami Cancer Institute
Dr. Villalona-Calero has indicated that neither he nor his spouse/ partner have relevant financial relationships to disclose and that his discussion will not include mention of investigational or
Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose.
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Florida Board of Laboratory Personnel
- 1.50 Florida Board of Nursing
- 1.50 Nurse Practitioners
- 1.50 Florida Board of Occupational Therapy
- 1.50 Florida Board of Pharmacy
- 1.50 Florida Board of Respiratory Therapy
- 1.50 General certificate of attendance